Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Ductal Adenocarcinoma (mPDAC)”

Showing 3 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06790602
What this trial is testing

Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)
University of California, San Diego 43
Early research (Phase 1)Ended earlyNCT06528093
What this trial is testing

Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Boehringer Ingelheim 8
Not applicableNot Yet RecruitingNCT07516392
What this trial is testing

Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)
Catholic University of the Sacred Heart 1,140

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation